ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
18 announcements
TTK Healthcare completed the sale of its "EVA" and "Good Home" brands to Wipro Enterprises. The company received Rs. 256 crore in cash consideration.
TTK Healthcare Limited has appointed M/s. R V K & Co., Chartered Accountants, as the Company's Tax Auditor. The appointment is for a three-year term covering FY 2025-26 to 2027-28.
TTK Healthcare Ltd announced that its tax auditor, M/s Aiyar & Co., resigned effective August 26, 2026. The auditor cited eligibility issues regarding their peer review certificate.
TTK Healthcare Ltd reported revenue from operations of ₹257.6 Cr (+13.8% YoY) and net profit of ₹21.3 Cr (+63.8% YoY) for Q1 FY27.
TTK Healthcare has scheduled a board meeting for August 06, 2026, to approve the company's unaudited financial results for the first quarter ended June 30, 2026.
TTK Healthcare Limited announced the re-appointment of Mr. Thiruvallur Thattai Raghunathan as Executive Director. The appointment is effective from November 1, 2026, for a term of 60 months.
TTK Healthcare Ltd held its 68th Annual General Meeting via video conferencing. The meeting included the declaration of a dividend of Rs.10.00 per share.
TTK Healthcare has agreed to sell its EVA and Good Home brands to Mipro Enterprises Private Limited. The total consideration for the sale is ₹256 Crore.
TTK Healthcare Ltd submitted its quarterly shareholding pattern for the period ending June 30, 2026. The filing details holdings across promoter and public categories.
TTK Healthcare submitted its Business Responsibility and Sustainability Report for FY 2025-26. The report outlines sustainability performance and general operational disclosures.
TTK Healthcare submitted its 68th Annual Report for FY 2025-26. The filing also includes the notice for the upcoming Annual General Meeting.
TTK Healthcare scheduled its 68th AGM for July 24, 2026. The Record Date for dividend and voting rights is fixed for July 17, 2026.
TTK Healthcare paid a ₹0.10 Crore customs penalty following product reclassification. The company settled the matter suo motto to ensure regulatory compliance and operational continuity.
TTK Healthcare Ltd reported revenue from operations of ₹218 Cr (+14.5% YoY) and net profit of ₹21.8 Cr (+35.4% YoY) for Q4 FY26.
TTK Healthcare approved audited FY26 results and recommended a Rs.10 per share dividend. The board also re-appointed Mr. T T Raghunathan as Executive Chairman for five years.
TTK Healthcare Limited submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report confirms overall regulatory adherence with no major non-compliances.
TTK Healthcare Ltd reported net profit of ₹10.5 Cr (-37.1% YoY) for Q3 FY26.
Bhanu Raghunathan, a promoter of TTK Healthcare Limited, submitted a declaration under SEBI Takeover Regulations for FY 2025-26. The filing confirms that no encumbrances or pledges were created on the promoter's holding of 56,000 equity shares during the period. This is a routine annual compliance disclosure.